Innoviva, Inc.
US ˙ NasdaqGS ˙ US45781M1018

SecurityINVA / Innoviva, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership248,819 shares
Latest Disclosed Value $ 5,797,483
D. E. Shaw & Co., Inc. ownership in INVA / Innoviva, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 248,819 shares of Innoviva, Inc. (US:INVA) valued at $5,797,483 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 371,432 shares of Innoviva, Inc.. This represents a change in shares of -33.01% during the quarter. The current value of the position is $5,399,372 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (INVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

INVA / Innoviva, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INNOVIVA COM 45781M101 248,819 -122,613 -33.01 5,797 -21.92 0.0035
2026-02-17 2025-12-31 13F INNOVIVA COM 45781M101 371,432 -364,301 -49.52 7,425 -44.71 0.0041
2025-11-14 2025-09-30 13F INNOVIVA COM 45781M101 735,733 -285,877 -27.98 13,427 -34.58 0.0076
2025-08-14 2025-06-30 13F INNOVIVA COM 45781M101 1,021,610 -139,911 -12.05 20,524 -2.54 0.0146
2025-05-15 2025-03-31 13F INNOVIVA COM 45781M101 1,161,521 318,874 37.84 21,058 44.05 0.0187
2025-02-14 2024-12-31 13F INNOVIVA COM 45781M101 842,647 184,595 28.05 14,620 15.06 0.0107
2024-11-14 2024-09-30 13F INNOVIVA COM 45781M101 658,052 -1,413 -0.21 12,707 17.48 0.0109
2024-08-14 2024-06-30 13F INNOVIVA COM 45781M101 659,465 -75,265 -10.24 10,815 -3.41 0.0101
2024-05-15 2024-03-31 13F INNOVIVA COM 45781M101 734,730 -36,288 -4.71 11,197 -9.46 0.0096
2024-02-14 2023-12-31 13F INNOVIVA COM 45781M101 771,018 60,395 8.50 12,367 33.99 0.0108
2023-11-14 2023-09-30 13F INNOVIVA COM 45781M101 710,623 95,114 15.45 9,231 17.80 0.0096
2023-08-14 2023-06-30 13F INNOVIVA COM 45781M101 615,509 -70,699 -10.30 7,835 1.50 0.0080
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 686,208 -292,916 -29.92 7,720 -40.50 0.0083
2023-02-14 2022-12-31 13F INNOVIVA COM 45781M101 979,124 46,803 5.02 12,973 19.85 0.0143
2022-11-14 2022-09-30 13F INNOVIVA COM 45781M101 932,321 921,909 8,854.29 10,824 18,562.07 0.0129
2022-08-15 2022-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 10,412 -1,201,850 -99.14 58 -99.75 0.0001
2022-08-15 2022-06-30 13F INNOVIVA COM 45781M101 1,153,734 -58,528 17,029 0.0200
2022-05-16 2022-03-31 13F INNOVIVA COM 45781M101 1,212,262 1,190,126 5,376.43 23,457 8,247.69 0.0220
2022-02-14 2021-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 22,136 -803,964 -97.32 281 -97.96 0.0002
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 798,993 -27,107 13,783 0.0114
2021-11-15 2021-09-30 13F INNOVIVA COM 45781M101 826,100 -9,759 -1.17 13,804 23.15 0.0125
2021-08-16 2021-06-30 13F INNOVIVA COM 45781M101 835,859 -213,539 -20.35 11,209 -10.61 0.0097
2021-05-17 2021-03-31 13F INNOVIVA COM 45781M101 1,049,398 -95,123 -8.31 12,540 -11.57 0.0121
2021-02-16 2020-12-31 13F INNOVIVA COM 45781M101 1,144,521 -90,447 -7.32 14,181 9.89 0.0127
2020-11-16 2020-09-30 13F INNOVIVA COM 45781M101 1,234,968 -116,709 -8.63 12,905 -31.71 0.0132
2020-08-14 2020-06-30 13F INNOVIVA COM 45781M101 1,351,677 -183,418 -11.95 18,897 4.68 0.0225
2020-05-15 2020-03-31 13F INNOVIVA COM 45781M101 1,535,095 -153,310 -9.08 18,053 -24.49 0.0282
2020-02-14 2019-12-31 13F INNOVIVA COM 45781M101 1,688,405 150,974 9.82 23,908 47.53 0.0273
2019-11-14 2019-09-30 13F INNOVIVA COM 45781M101 1,537,431 -420,301 -21.47 16,205 -43.15 0.0200
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 1,957,732 -178,386 -8.35 28,505 -4.89 0.0355
2019-05-15 2019-03-31 13F INNOVIVA COM 45781M101 2,136,118 179,798 9.19 29,969 -12.21 0.0387
2019-02-14 2018-12-31 13F INNOVIVA COM 45781M101 1,956,320 1,001,636 104.92 34,138 134.64 0.0470
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 954,684 482,603 102.23 14,549 123.32 0.0175
2018-08-14 2018-06-30 13F INNOVIVA COM 45781M101 472,081 276,624 141.53 6,515 99.97 0.0085
2018-05-15 2018-03-31 13F INNOVIVA COM 45781M101 195,457 -379,035 -65.98 3,258 -60.04 0.0044
2018-02-14 2017-12-31 13F INNOVIVA COM 45781M101 574,492 -297,091 -34.09 8,153 -33.75 0.0112
2017-11-14 2017-09-30 13F INNOVIVA COM 45781M101 871,583 151,340 21.01 12,307 33.50 0.0189
2017-08-14 2017-06-30 13F INNOVIVA COM 45781M101 720,243 -447,695 -38.33 9,219 -42.93 0.0152
2017-05-15 2017-03-31 13F INNOVIVA COM 45781M101 1,167,938 549,932 88.98 16,153 144.26 0.0284
2017-02-14 2016-12-31 13F INNOVIVA COM 45781M101 618,006 -190,430 -23.56 6,613 -25.57 0.0112
2016-11-14 2016-09-30 13F INNOVIVA COM 45781M101 808,436 304,793 60.52 8,885 67.55 0.0157
2016-08-15 2016-06-30 13F INNOVIVA COM 45781M101 503,643 100,686 24.99 5,303 4.53 0.0098
2016-05-16 2016-03-31 13F INNOVIVA COM 45781M101 402,957 152,255 60.73 5,073 92.01 0.0091
2016-02-16 2015-12-31 13F THERAVANCE COM 88338T104 250,702 210,861 529.26 2,642 823.78 0.0039
2015-11-16 2015-09-30 13F THERAVANCE COM 88338T104 39,841 -97,664 -71.03 286 -88.49 0.0004
2015-08-14 2015-06-30 13F THERAVANCE COM 88338T104 137,505 -58,232 -29.75 2,485 -19.24 0.0037
2015-05-15 2015-03-31 13F THERAVANCE COM 88338T104 195,737 -468 -0.24 3,077 10.84 0.0047
2015-02-17 2014-12-31 13F THERAVANCE COM 88338T104 196,205 -422,594 -68.29 2,776 -73.75 0.0036
2014-11-14 2014-09-30 13F THERAVANCE COM 88338T104 618,799 246,352 66.14 10,575 -4.65 0.0137
2014-08-14 2014-06-30 13F THERAVANCE COM 88338T104 372,447 96,938 35.19 11,091 30.11 0.0151
2014-05-15 2014-03-31 13F THERAVANCE COM 88338T104 275,509 22,845 9.04 8,524 -5.37 0.0122
2014-02-14 2013-12-31 13F THERAVANCE COM 88338T104 252,664 46,084 22.31 9,008 6.64 0.0123
2013-11-20 2013-09-30 13F/A-1 THERAVANCE COM 88338T104 206,580 206,580 8,447 0.0135
2013-11-14 2013-09-30 13F THERAVANCE COM 88338T104 206,580 8,447 0.0135
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-05-15 2015-03-31 13F THERAVANCE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F THERAVANCE COM Call 60,000 0.00 849 -17.17 n/a n/a n/a
2014-11-14 2014-09-30 13F THERAVANCE COM Call 60,000 0.00 1,025 -42.64 n/a n/a n/a
2014-08-14 2014-06-30 13F THERAVANCE COM Call 60,000 0.00 1,787 -3.72 n/a n/a n/a
2014-05-15 2014-03-31 13F THERAVANCE COM Call 60,000 0.00 1,856 -13.23 n/a n/a n/a
2014-02-14 2013-12-31 13F THERAVANCE COM Call 60,000 0.00 2,139 -12.80 n/a n/a n/a
2013-11-20 2013-09-30 13F/A THERAVANCE COM Call 60,000 50.00 2,453 59.18 n/a n/a n/a
2013-11-14 2013-09-30 13F THERAVANCE COM Call 60,000 2,453 n/a n/a n/a
2013-08-14 2013-06-30 13F THERAVANCE COM Call 40,000 1,541 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-02-14 2013-12-31 13F THERAVANCE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-20 2013-09-30 13F/A THERAVANCE COM Put 5,400 221 n/a n/a n/a
2013-11-14 2013-09-30 13F THERAVANCE COM Put 5,400 221 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.